CAS编号 | 1610761-46-0 |
抗体名 | Plozalizumab ( 洛扎利珠单抗 ) |
靶点 | CCR2/CD192[Homo sapiens] |
纯度 | % |
产地 | 中国 |
品牌 | Chemstan |
货号 | CSD00399 |
保存条件 | store at -80℃ |
抗原来源 | CHO cells |
保质期 | 一年 |
规格 | 100μg |
产品用途 | 仅用于科研用途 |
浓度 | 95% |
是否进口 | 否 |
Plozalizumab has been investigated for the treatment of Atherosclerosis. Plozalizumab, a novel humanized monoclonal antibody, specifically targets CCR2 chemokine receptors found on the surface of certain white blood cells including macrophages and monocytes. Preclinical studies suggest that CCR2 plays an important role in the trafficking of monocytes and macrophages to sites of inflammation. The recruitment of macrophages to the arterial wall is believed to be a critical step in the development of atherosclerosis.
货号(Catalog No.)
CSD00399
通用名INN
Plozalizumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Plozalizumab has been investigated for the treatment of Atherosclerosis. Plozalizumab, a novel humanized monoclonal antibody, specifically targets CCR2 chemokine receptors found on the surface of certain white blood cells including macrophages and monocytes. Preclinical studies suggest that CCR2 plays an important role in the trafficking of monocytes and macrophages to sites of inflammation. The recruitment of macrophages to the arterial wall is believed to be a critical step in the development of atherosclerosis.
别名(Alternative names)
MLN-1202,anti-CCR2,hu1D9
靶点;物种(Specificity target name;species)
CCR2/CD192[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
1610761-46-0
存储条件(Storage)
store at -80°C
15926423062
武汉科斯坦生物科技有限公司 版权所有(C)2024 XML 技术支持: 盖德化工网 食品商务网
武汉科斯坦生物科技有限公司